Cargando…
037 Is Oral Testosterone a Potential Treatment for COVID-19 in Men?
Autores principales: | Papangkorn, K., Bruno, B., DelConte, A., Chidambaram, N., Kim, K., Patel, M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7963469/ http://dx.doi.org/10.1016/j.jsxm.2021.01.106 |
Ejemplares similares
-
Low Testosterone in Males May Warrant Liver Health Assessment and Intervention
por: DelConte, Anthony, et al.
Publicado: (2021) -
SAT-052 A Novel Oral Testosterone Therapy (TLANDO) Safely Restores Testosterone to Eugonadal Levels with Fixed Dose Treatment
por: DelConte, Anthony, et al.
Publicado: (2020) -
A new oral testosterone (TLANDO) treatment regimen without dose titration requirement for male hypogonadism
por: DelConte, Anthony, et al.
Publicado: (2022) -
SAT-038 Ambulatory Blood Pressure Increases in Hypogonadal Men Who Develop Increases in Hematocrit on Oral Testosterone Undecanoate
por: Dobs, Adrian Sandra, et al.
Publicado: (2020) -
TLANDO, a Novel Oral TRT, Improves Sexual and Mental Domain Outcomes in Hypogonadal Men
por: Bruno, Benjamin J, et al.
Publicado: (2021)